How will the addition of step therapy on Medicare Part B drugs impact biosimilars?
Increase use of biosimilars: 54.55%
No Change: 36.36%
Decrease biosimilar use: 9.09%
September 2026 Question of the Month Results
October 1, 2026
September 2018 Question of the Month
Stay Up to Date
September 2018 Question of the Month
Recent Posts
Drug Shortages Are Improving, but Supply Chain Bottlenecks Remain a Threat
September 15, 2026
August 2026 Question of the Month Results
September 2, 2026